Aldosterone mediates potassium-induced kidney fibrosis through tubular and mesenchymal mineralocorticoid receptor activation

For decades, doctors have advised patients with chronic kidney disease to avoid foods rich in potassium, such as bananas, oranges, and leafy greens. The fear is that failing kidneys cannot filter this mineral out of the blood, leading to dangerous levels that can stop the heart. This advice has become a standard part of managing kidney health. However, the story of potassium is more complex than a simple "good" or "bad" label. While high potassium can be immediately life-threatening, the mineral also plays a vital role in regulating blood pressure and protecting the heart. Recent guidelines have begun to suggest that for some patients, the benefits of potassium-rich foods might outweigh the risks, provided the levels in the blood are monitored. Yet, a critical question remained unanswered: could high levels of potassium, even when managed by the body, be silently damaging the kidneys in a different way?

A new study from researchers at the University of Geneva and the University of Texas Southwestern Medical Center investigates this hidden danger. The scientists focused on a specific mechanism involving a hormone called aldosterone. In a healthy body, when potassium levels rise, the adrenal glands release aldosterone to help the kidneys flush the excess mineral out. This hormone acts like a switch, turning on specific channels in the kidney to move potassium into the urine. However, aldosterone also has a second, less understood effect: it can trigger scarring, known as fibrosis, within the kidney tissue. Fibrosis is the stiffening and scarring of the organ that eventually leads to kidney failure. The researchers wanted to know if the very process of handling high potassium—driven by aldosterone—might be accelerating this scarring process, turning a necessary survival response into a slow poison for the kidney.

To find the answer, the team turned to mice, using two different models to simulate kidney injury. In the first model, they blocked one of the ureters, the tubes that carry urine from the kidney to the bladder, causing immediate stress and scarring. In the second model, they induced damage specifically to the filtering units of the kidney, known as glomeruli. They then fed these mice diets with varying amounts of potassium, ranging from very low to very high levels. The results were striking. In both models, the mice eating the high-potassium diets developed significantly more scarring in their kidneys than those on normal or low-potassium diets. The damage was not just a little worse; in the model of glomerular injury, the high-potassium group saw their kidney filtration rate drop by approximately 50% compared to the normal group.

The researchers then asked whether this damage was caused by the potassium itself or by the salt often found with it. They tested this by changing the type of salt in the diet and by swapping the potassium for a different chemical form. The scarring persisted regardless of these changes, proving that the potassium itself was the driver. The team also measured the levels of aldosterone in the blood and found a clear link: as the potassium intake went up, so did the aldosterone, and the amount of scarring increased in direct proportion to the hormone levels. This suggested that the body's attempt to clear the potassium was the actual cause of the damage.

To confirm that aldosterone was the culprit, the scientists used a drug called finerenone, which blocks the receptor that aldosterone uses to send its signals. When they gave this drug to the mice on high-potassium diets, the scarring was attenuated, though the effect did not reach statistical significance in all metrics. This proved that the damage was not an unavoidable consequence of eating potassium, but rather a specific reaction to the hormone's activation. The study went a step further to identify exactly which cells in the kidney were being harmed. Using advanced genetic techniques, they created mice that lacked the aldosterone receptor in specific types of cells. They found that when the receptor was removed from the kidney's tubule cells (which handle fluid transport) or from the mesenchymal cells (which support the tissue structure), the high-potassium diet no longer caused scarring. However, removing the receptor from immune cells did not have the same effect. This pinpointed the tubule and support cells as the specific targets where the hormone drives the fibrosis.

These findings challenge the simple view that potassium is only dangerous when it causes immediate blood level spikes. The study suggests that even when the body successfully manages high potassium intake, the resulting surge in aldosterone can act as a silent accelerator of kidney scarring. The researchers noted that the potassium levels used in the study were quite high, representing an extreme intake that might be more comparable to heavy supplementation than a typical diet. Nevertheless, the mechanism they uncovered provides a new explanation for why some patients with chronic kidney disease progress faster than others. It suggests that for some individuals, the body's own response to dietary potassium might be the very thing that drives their disease forward.

The implications of this work are significant for how kidney disease is managed in the future. It highlights that the relationship between diet and kidney health is not just about what is in the food, but how the body reacts to it. The study indicates that monitoring aldosterone levels could help doctors identify which patients are most at risk from high potassium intake and who might benefit most from treatments that block the hormone's effects. While the study was conducted in mice and used acute injury models, it provides the first genetic evidence that the specific cells responsible for kidney scarring are the tubule and mesenchymal cells, and that their activation by aldosterone is a key driver of the disease. This opens a new path for understanding kidney failure, suggesting that the solution might lie not just in restricting diet, but in managing the hormonal signals that the diet triggers.